News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Global MPNSF – The EHA Congress 2024 has been a resounding success
Photo taken from Global MPNSF/LinkedIn
Jun 25, 2024, 08:21

Global MPNSF – The EHA Congress 2024 has been a resounding success

shared on LinkedIn:

“The EHA Congress 2024 has been a resounding success!.
Explore the advancements in hematology, new therapies for myeloproliferative neoplasms, and inspiring patient stories.

Discover how the MPN Spain community continues to make a difference in research and treatment. Don’t miss out!

Connect with us and be part of the change on our blog.”

Global MPNSF

Read further.
Source: Global MPNSF/LinkedIn

cancer EHA Congress 2024 Global MPNSF Hematology inspiring patient stories myeloproliferative neoplasms OncoDaily Oncology
Special Coverage
Insight
Sep 6, 2024, 07:17
The first case of Lung Cancer detected by AI in Malaysia
Blog
Sep 6, 2024, 07:04
The first phase III trials of SBRT+/- Checkpoint inhibitors for stage 1 NSCLC
Insight
Sep 6, 2024, 07:04
Tracey O’Brien: Harnessing digital health for enhanced cancer research and patient outcomes
Insight
Sep 6, 2024, 06:53
Piotr Wysocki: Belzutifan represents an active treatment option in highly pretreated ccRCC patients
Blog
Sep 6, 2024, 02:34
Andrius Žučenka: Losing a patient is hard, but losing the youngest ones is extremely tough
Insight
Sep 6, 2024, 02:23
Gustavo Alencastro Veiga Cruzeiro: Diffuse hemispheric glioma, H3G34R/V-mutant
Blog
Sep 6, 2024, 01:59
Soma Sengupta: Excited to participate in the AARN
Blog
Sep 5, 2024, 19:56
Miriam Mutebi: Basic science is the foundation upon which modern cancer care is built
Blog
Sep 5, 2024, 19:44
Alexa Morell about the alarming increase in colorectal cancer among young adults - Agenus
Blog
Sep 5, 2024, 19:39
Results of Childhood Cancer International's ICCD Campaign
Insight
Sep 5, 2024, 19:32
Francisco Esteva: HER2-targeted therapies are being explored for various other solid tumors
Blog
Sep 5, 2024, 19:22
Arif Kamal: Cancer is not a red vs. blue issue, it's a human issue